ADF

:   actin‐depolymerizing factor

ADP

:   adenosine diphosphate

ATP

:   adenosine triphosphate

cAMP

:   cyclic adenosine monophosphate

DEG

:   differentially expressed gene

DNA

:   deoxyribonucleic acid

FPKM

:   fragments per kilobase of transcript per million mapped reads

FRAP

:   fluorescence recovery after photobleaching

GFP

:   green fluorescence protein

GO

:   gene ontology

RNA

:   ribonucleic acid

RNA‐Seq

:   RNA sequencing

sfGFP

:   superfold GFP

Tpm

:   tropomyosin

The actin cytoskeleton provides structural support and is essential for the cellular morphogenesis of eukaryotic cells and many physiological processes including cell motility, endocytosis, transport of organelles, apoptosis, and the maintenance of correct directional signal transmission in neurons [1](#feb412386-bib-0001){ref-type="ref"}, [2](#feb412386-bib-0002){ref-type="ref"}. Several actin‐binding proteins are known to bestow the actin cytoskeleton with a high degree of structural and functional diversity by regulating actin filament turnover, filament branching, bundling, and cross‐linking of individual filaments [3](#feb412386-bib-0003){ref-type="ref"}. Tropomyosins (Tpms) are a large family of actin‐binding proteins that are generated by alternative splicing from four different genes (*Tpm1*,*Tpm2*,*Tpm3,* and *Tpm4*). They not only define distinct filamentous actin populations in different cell populations and subcellular compartments, but also regulate the access of other actin‐binding proteins to the actin filament [4](#feb412386-bib-0004){ref-type="ref"}, [5](#feb412386-bib-0005){ref-type="ref"}. Tpms have been identified to play an important role in a range of cellular processes with changes in protein expression, including the regulation of cell transformation [6](#feb412386-bib-0006){ref-type="ref"}, [7](#feb412386-bib-0007){ref-type="ref"}, ERK‐mediated proliferation [8](#feb412386-bib-0008){ref-type="ref"}, insulin‐stimulated GLUT4 transport [9](#feb412386-bib-0009){ref-type="ref"}, and anoikis [10](#feb412386-bib-0010){ref-type="ref"}. The regulation of these diverse cellular processes suggests that an altered composition of Tpm expression in eukaryotic cells will lead to changes in cellular pathways at a global level rather than impacting on interactions with only a select number of established interaction partners. In this study, we aimed to test whether the level of expression of Tpms determines the cell transcriptome in an isoform‐specific manner and whether these changes are dependent on the differentiation stage of these cells. Rat B35 neuroblastoma cells [11](#feb412386-bib-0011){ref-type="ref"}, [12](#feb412386-bib-0012){ref-type="ref"} have extensively been used to study cellular processes of eukaryotic cells, including neuronal morphogenesis [11](#feb412386-bib-0011){ref-type="ref"}, [13](#feb412386-bib-0013){ref-type="ref"}, cell motility [14](#feb412386-bib-0014){ref-type="ref"}, [15](#feb412386-bib-0015){ref-type="ref"}, vesicular trafficking [16](#feb412386-bib-0016){ref-type="ref"}, and apoptosis [17](#feb412386-bib-0017){ref-type="ref"}, [18](#feb412386-bib-0018){ref-type="ref"}. Our group has used the B35 cell system previously to study the role of different Tpm isoforms in neuronal cell morphogenesis [13](#feb412386-bib-0013){ref-type="ref"}, [19](#feb412386-bib-0019){ref-type="ref"}. Stable rat B35 neuroblastoma cell lines overexpressing the Tpm isoforms Tpm1.12, Tpm2.1, Tpm3.1, and Tpm4.2, from each of the Tpm genes 1‐4, were previously generated [13](#feb412386-bib-0013){ref-type="ref"}, [17](#feb412386-bib-0017){ref-type="ref"}, [19](#feb412386-bib-0019){ref-type="ref"}. Neuronal differentiation requires the coordinated reorganization of the actin cytoskeleton to facilitate the sprouting and elongation of neurites, which ultimately form axons and dendrites. Our previous studies showed that the overexpression of Tpms in B35 cells was not only sufficient to induce the formation of neurites, but also differentially influenced neurite branching and extension in differentiating B35 cells [13](#feb412386-bib-0013){ref-type="ref"}.

In this study, we wanted to understand how the transcriptome of B35 cells is altered in response to the overexpression of different Tpm isoforms. The analysis of the transcriptome does not only provide insight into which genes are being expressed, and at what level, but also sheds light onto how the distinct expression of genes could alter essential cellular pathways and mechanisms of cellular morphogenesis.

We employed Illumina RNA‐seq which has been demonstrated to yield higher sensitivity, deeper resolution, and greater reproducibility when compared to conventional genomic methods such as microarray analysis [20](#feb412386-bib-0020){ref-type="ref"}. Another advantage of RNA‐seq is the ability to identify novel transcripts and splice variants, which is not possible using microarray analysis. To identify gene clusters of biological pathways, which may reveal hidden patterns that regulate specific biological processes, differentially expressed genes (DEGs) were further analyzed via clusterProfiler. The main advantage of clusterProfiler is the application of both biological term classification and enrichment analysis to gene cluster analysis, thereby providing greater insight into understanding higher order functions in biological systems [21](#feb412386-bib-0021){ref-type="ref"}. We found a large number of changes in genes in undifferentiated B35 cells, compared with differentiated cells, where Tpm overexpression appeared to have less influence on gene expression. Differentially expressed genes (DEGs) found in undifferentiated cells could be grouped into a range of different pathways, including pronounced changes in actin‐binding pathways. However, in differentiated cells, only one isoform, Tpm3.1, had DEGs that generated gene ontology (GO) terms, suggesting limited pathway commonality in differentiated Tpm1.12, Tpm2.1, and Tpm4.2 B35 cells. Our results are consistent with the overall hypothesis that different Tpm isoforms generate distinct actin filament populations that are controlling key pathways of cellular function in eukaryotic cells.

Materials and methods {#feb412386-sec-0004}
=====================

Cell culture, differentiation, and harvesting {#feb412386-sec-0005}
---------------------------------------------

B35 rat neuroblastoma cells, stably overexpression of different Tpm isoforms, were previously described for the overexpression of Tpm1.12 and Tpm3.1 [19](#feb412386-bib-0019){ref-type="ref"}, Tpm2.1 [17](#feb412386-bib-0017){ref-type="ref"}, and Tpm4.2 [13](#feb412386-bib-0013){ref-type="ref"}. Cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM; Invitrogen, Life Technologies, Melbourne, Vic., Australia), 0.6% geneticin (Invitrogen, Life Technologies), and 10% heat‐inactivated fetal bovine serum (FBS; Invitrogen, Life Technologies) at 37 °C in a 5% CO~2~ incubator. To differentiate the cells, media was changed to DMEM containing 0.1% FBS, 0.5 m[m]{.smallcaps} cyclic adenosine monophosphate (cAMP) 24 h prior to harvesting. Cells were harvested by incubation with 1% trypsin in phosphate‐buffered saline and pelleting of the cells via centrifugation at 300 g for 10 min. The pellets were snap‐frozen in liquid nitrogen and stored at −80 °C until RNA sequencing.

RNA preparation and sequencing {#feb412386-sec-0006}
------------------------------

Total RNA was isolated from three biological replicates from each transgenic cell line and empty vector control‐transfected cells, using RNeasy Mini Kit (Qiagen, Hilden, Germany) followed by RNase‐free DNase treatment to remove traces of genomic DNA. The Agilent 2100 Bioanalyzer RNA Nano Chip was used to assess the RNA quality of the total RNA. The RNA integrity number (RIN) values ranged between 6.0 and 7.0. RNA was generated using Illumina TruSeq RNA sample preparation for poly(A) RNA and sequenced using paired‐end 100‐bp reads on Illumina HiSeq2500.

Read mapping, transcript assembly, and comparative analysis {#feb412386-sec-0007}
-----------------------------------------------------------

Sequencing files in FASTQ format were uploaded to Galaxy server at <http://usegalaxy.org> sequence reads mapped to the rat reference genome (Rnor_6.0) using TopHat (version 2.1.1) as described previously [22](#feb412386-bib-0022){ref-type="ref"}. The BAM files from TopHat were then fed into Cufflinks (version: 2.2.1) on Galaxy server for transcript assembly and expression level calculation. Annotation files from Ensembl rat genome assembly Rnor_6.0 were used as reference annotation. Next, Cufflinks‐assembled transcripts were merged together using Cuffmerge on Galaxy server using uploaded reference annotation. Differential expression analysis was performed using Cuffdiff. Cuffdiff utilizes the merged files from Cuffmerge along with the original alignment files produced from TopHat to calculate expression levels and determine their statistical significance and whether the transcripts are differentially expressed. Genes with an FPKM ≥ 1 in at least one condition were considered as expressed.

Pathway analysis {#feb412386-sec-0008}
----------------

The ClusterProfiler program [21](#feb412386-bib-0021){ref-type="ref"} was used through the platform R studio (<https://www.rstudio.com/>) version 1.0.143 to undertake the pathway analysis of the significant differentially expressed linear RNA. Pathway analysis included matching the input list of annotated genes expressing linear RNA to their ENTREZ ID. These genes were then matched to their respective GO terms, and an over‐representation test, based on hypergeometric distribution of the GO terms, was performed to identify enriched GO terms and subsequently measure the statistical significance of each enriched GO term. For this pathway analysis, the allocated ontology term option used was biological processes. The scripts used for the pathway analysis were obtained from <https://bioconductor.org/packages/devel/bioc/vignettes/clusterProfiler/inst/doc/clusterProfiler.html>.

Results and Discussion {#feb412386-sec-0009}
======================

Overexpression of tropomyosin isoforms differentially affects gene expression in undifferentiated and differentiated B35 neuroblastoma cells {#feb412386-sec-0010}
--------------------------------------------------------------------------------------------------------------------------------------------

In undifferentiated cells, the overexpression of specific Tpm isoforms alters the expression of thousands of genes, with a surprising degree of difference in effected genes between isoforms (Fig. [1](#feb412386-fig-0001){ref-type="fig"}A). Cells with increased levels of Tpm1.12 had changes in the expression of over 4000 genes, the highest number of observed DEGs out of the four isoforms investigated. Approximately 45% of these DEGs were specific to Tpm1.12‐overexpressing cells. Tpm2.1, Tpm3.1 and Tpm4.2 each had between 2000 and 2400 DEGs with isoform specificity ranging between 15 and 20%.

![Overexpression of Tpm isoforms differentially regulates gene expression in undifferentiated and differentiated rat B35 neuroblastoma cells. (A) In undifferentiated cells, overexpression of tropomyosin isoforms 1.12, 2.1, 3.1, and 4.2 differentially regulates a large number of genes with partial overlap between isoforms. (B) Once differentiated, Tpm isoforms have a weaker influence on gene expression and less overlap between isoforms compared with undifferentiated cells.](FEB4-8-570-g001){#feb412386-fig-0001}

In differentiated cells, numbers of DEGs were overall greatly reduced compared with undifferentiated cells (Fig. [1](#feb412386-fig-0001){ref-type="fig"}B). The highest number of DEGs observed was 160 and again associated with Tpm1.12 overexpression. Differentiated cells, overexpressing Tpm3.1 and Tpm4.2, had similar numbers of DEGs, 120 and 136, respectively. Tpm2.1 had, with 89, the fewest number of DEGs. In terms of specificity, once differentiated, there was also reduced overlap between isoforms. Tpm3.1 showed relatively high specificity, with over 60% of observed DEGs being unique to cells, overexpressing this isoform. Tpm2.1 and Tpm4.2 isoforms had specificity ranging between 49% and 43%, respectively, much greater than observed in undifferentiated cells. Tpm1.12 was the only isoform that showed similar specificity of approximately 45%, regardless of whether the cells were differentiated or not. Overall, these results indicate that Tpms exert a broad influence on gene expression in undifferentiated cells. However, once cells undergo differentiation, gene expression appears more tightly regulated with tropomyosin having a weaker but more isoform‐specific influence.

Undifferentiated Tpm1.12‐, Tpm3.1‐, and Tpm4.2‐overexpressing B35 cells display some similarity in gene regulation {#feb412386-sec-0011}
------------------------------------------------------------------------------------------------------------------

In undifferentiated cells, there was some commonality between the different cell lines (Table [1](#feb412386-tbl-0001){ref-type="table-wrap"}). In undifferentiated Tpm1.12‐overexpressing cells, *Ntm,* which encodes for a protein that inhibits neurite outgrowth [23](#feb412386-bib-0023){ref-type="ref"}, was the most downregulated gene. Within undifferentiated Tpm2.1 cells, *Bnc1* was among the top upregulated genes. Bnc1 is a transcription factor that plays a role in the expression of genes involved in cellular differentiation and proliferation [24](#feb412386-bib-0024){ref-type="ref"}. In Tpm3.1‐ and Tpm4.2‐overexpressing B35 cells, the gene encoding for neurofilament light chain, *Nefl*, was among the top downregulated genes, suggesting cross‐talk between the actin and intermediate filament systems. Together, this indicates the greatest commonality between Tpm3.1‐ and Tpm4.2‐overexpressing cells, both in the undifferentiated and in differentiated states. The similarity in effects of Tpm3.1 and Tpm4.2 has also been observed in other systems. *In vitro* single filament assays have shown that Tpm3.1 and Tpm4.2 often localize to the same F‐actin populations and have similar, rapid association with less cooperative binding to F‐actin [25](#feb412386-bib-0025){ref-type="ref"}. This was analyzed using FRAP experiments where the fluorescence recovery of sfGFP (super‐folder GFP) fusions of Tpm3.1 and Tpm4.2 was much more rapid, when compared to higher molecular weight Tpm isoforms. These isoforms also stimulate the ATPase activity of nonmuscle myosin IIa and, *in vitro*, do not efficiently protect filaments from the severing action of ADF/cofilin [25](#feb412386-bib-0025){ref-type="ref"}.

###### 

Top 10 up‐ and downregulated genes in undifferentiated B35 neuroblastoma cells overexpressing tropomyosin isoforms Tpm1.12, Tpm2.1, Tpm3.1, and Tpm4.2

  Gene                                   Locus                                FPKM_Tpm1.12   FPKM_WT     Fold change   *P*\_value   *q*\_value   Gene_id       Gene       Locus   FPKM_Tpm1.12   FPKM_WT   Fold change   *P*\_value   *q*\_value   Gene_id
  -------------------------------------- ------------------------------------ -------------- ----------- ------------- ------------ ------------ ------------- ---------- ------- -------------- --------- ------------- ------------ ------------ -------------
  Tpm1.12 undiff. top 10 downregulated   Tpm1.12 undiff. Top 10 upregulated                                                                                                                                                                        
  Ntm                                    chr8                                 4.5128         0.224026    −4.33228      5.00E‐05     0.00040997   XLOC_019559   --         chr2    0.330884       10.2837   4.95789       5.00E‐05     0.00040997   XLOC_011049
  Krt15                                  chr10                                288.734        14.6227     −4.30346      5.00E‐05     0.00040997   XLOC_004359   Rab15      chr6    0.0990585      3.02151   4.93084       0.0002       0.0014157    XLOC_017230
  Chrdl1                                 chrX:                                1.73954        0.0968726   −4.16647      5.00E‐05     0.00040997   XLOC_021556   --         chr15   0.0684066      1.87164   4.77403       0.0002       0.0014157    XLOC_007916
  RGD1563159                             chr18                                3.41646        0.21943     −3.96067      5.00E‐05     0.00040997   XLOC_009428   Klf12      chr15   0.0662939      1.5938    4.58745       5.00E‐05     0.00040997   XLOC_007841
  Kit                                    chr14                                2.38455        0.17741     −3.74856      5.00E‐05     0.00040997   XLOC_007027   --         chr12   0.598639       13.742    4.52077       5.00E‐05     0.00040997   XLOC_005277
  Rn18s, Rn45s, Rn5‐8s                   chr14                                2921.03        236.372     −3.62735      5.00E‐05     0.00040997   XLOC_006757   Kdf1       chr5    0.0728308      1.66214   4.51235       0.00055      0.00339959   XLOC_015675
  Clec2 dl1                              chr4                                 16.5433        1.44599     −3.51611      5.00E‐05     0.00040997   XLOC_014476   --         chr3    0.313492       6.41526   4.35501       5.00E‐05     0.00040997   XLOC_012148
  --                                     chr3                                 5.1911         0.512821    −3.33951      0.00175      0.00899966   XLOC_012887   Spp1       chr14   0.0841515      1.66596   4.30722       0.0026       0.0124381    XLOC_006940
  Ptpn7                                  chr13                                14.9719        1.481       −3.33761      5.00E‐05     0.00040997   XLOC_006040   Spon1      chr1    0.205599       3.44618   4.06709       5.00E‐05     0.00040997   XLOC_000788
  Hs3st6                                 chr10                                2.46299        0.248645    −3.30825      0.0028       0.0132381    XLOC_003048   Igf2 bp1   chr10   0.257626       3.9438    3.93624       5.00E‐05     0.00040997   XLOC_004304

  Gene                                  Locus                                FPKM_Tpm2.1   FPKM_WT    Fold change   *P*\_value   *q*\_value   Gene_id       Gene      Locus   FPKM_Tpm1.12   FPKM_WT   Fold change   *P*\_value   *q*\_value   Gene_id
  ------------------------------------- ------------------------------------ ------------- ---------- ------------- ------------ ------------ ------------- --------- ------- -------------- --------- ------------- ------------ ------------ -------------
  Tpm2.1 undiff. top 10 downregulated   Tpm2.1 undiff. Top 10 up‐regulated                                                                                                                                                                     
  Pcdh9                                 chr15                                74.6347       1.24766    −5.90255      5.00E‐05     0.00040997   XLOC_007836   Rab15     chr6:   0.068894       3.02151   5.45475       0.004        0.0177903    XLOC_017230
  Aqp8                                  chr1                                 24.1952       1.10004    −4.4591       5.00E‐05     0.00040997   XLOC_000830   Pdpn      chr5    1.13354        13.7824   3.60392       5.00E‐05     0.00040997   XLOC_016368
  Ntm                                   chr8                                 3.29835       0.224026   −3.88001      5.00E‐05     0.00040997   XLOC_019559   Clec12a   chr4    0.366014       3.56542   3.2841        0.00125      0.00679032   XLOC_014481
  Cnrip1                                chr14                                1.60263       0.145715   −3.45922      0.01095      0.0400834    XLOC_006874   Qprt      chr1    0.761786       6.36273   3.06219       5.00E‐05     0.00040997   XLOC_002237
  Ptpn7                                 chr13                                13.9013       1.481      −3.23057      5.00E‐05     0.00040997   XLOC_006040   --        chr11   0.358316       2.71438   2.92132       0.0014       0.00745855   XLOC_004806
  --                                    chr7                                 4.78368       0.511835   −3.22437      5.00E‐05     0.00040997   XLOC_018001   Bnc1      chr1    0.87852        6.59516   2.90826       5.00E‐05     0.00040997   XLOC_001936
  --                                    chr5                                 6.86562       0.755452   −3.18398      0.01145      0.0415397    XLOC_016457   --        chr2    0.64662        4.39964   2.76639       0.0031       0.0144126    XLOC_011435
  Dusp27                                chr13                                3.3696        0.451684   −2.89919      5.00E‐05     0.00040997   XLOC_006430   --        chr5    0.846829       5.75961   2.76583       5.00E‐05     0.00040997   XLOC_015850
  --                                    chr6                                 27.8064       3.923      −2.82539      0.00715      0.0285097    XLOC_017447   Cpq       chr7    0.209266       1.4142    2.75658       0.0016       0.00835597   XLOC_017738
  Socs2                                 chr7                                 5.24415       0.757575   −2.79125      5.00E‐05     0.00040997   XLOC_018257   Vsig10    chr12   0.423961       2.77583   2.71092       5.00E‐05     0.00040997   XLOC_005799

  Gene                                  Locus                                FPKM_Tpm3.1   FPKM_WT    Fold change   *P*\_value   *q*\_value   Gene_id       Gene         Locus   FPKM_Tpm1.12   FPKM_WT   Fold change   *P*\_value   *q*\_value   Gene_id
  ------------------------------------- ------------------------------------ ------------- ---------- ------------- ------------ ------------ ------------- ------------ ------- -------------- --------- ------------- ------------ ------------ -------------
  Tpm3.1 undiff. top 10 downregulated   Tpm3.1 undiff. Top 10 up‐regulated                                                                                                                                                                        
  --                                    chr10                                3.14938       0.088868   −5.14726      0.0002       0.0014157    XLOC_004626   Gabra1       chr10   0.970416       32.1676   5.05086       5.00E‐05     0.00040997   XLOC_003914
  Kcnn4                                 chr1                                 22.3992       0.757394   −4.88626      5.00E‐05     0.00040997   XLOC_000310   --           chr5    0.168244       3.14325   4.22363       0.0002       0.0014157    XLOC_016486
  Nefl                                  chr15                                47.6865       1.67599    −4.8305       5.00E‐05     0.00040997   XLOC_007467   Nfia         chr5    0.107033       1.64896   3.94543       0.0033       0.0151739    XLOC_015473
  --                                    chr19                                10.7555       0.456691   −4.55771      5.00E‐05     0.00040997   XLOC_010104   Ndn          chr1    0.780198       8.50889   3.44706       5.00E‐05     0.00040997   XLOC_000525
  --                                    chr15                                2.9081        0.143898   −4.33695      0.00095      0.00540022   XLOC_007901   RGD1312005   chr18   0.283849       2.89758   3.35165       5.00E‐05     0.00040997   XLOC_009262
  --                                    chr1:                                1.66185       0.088369   −4.23311      0.00225      0.0110774    XLOC_002911   Ptprk        chr1    0.13888        1.38178   3.31462       0.00165      0.00857402   XLOC_001371
  --                                    chr12                                2.22161       0.119614   −4.21515      5.00E‐05     0.00040997   XLOC_005896   Klf12        chr15   0.175186       1.5938    3.1855        5.00E‐05     0.00040997   XLOC_007841
  --                                    chr7                                 2.66362       0.155953   −4.09421      5.00E‐05     0.00040997   XLOC_018783   --           chr1    0.454788       3.90208   3.10098       5.00E‐05     0.00040997   XLOC_001370
  Lpl                                   chr16                                12.7953       0.820023   −3.96381      5.00E‐05     0.00040997   XLOC_008294   Clstn2       chr8    0.172923       1.28356   2.89195       0.0004       0.00258675   XLOC_019864
  --                                    chr7                                 1.99245       0.132793   −4.01647      0.0002       0.0014157    XLOC_018784   Mag          chr1    10.9565        74.1972   2.75958       5.00E‐05     0.00040997   XLOC_001722

  Gene                                  Locus                                FPKM_Tpm4.2   FPKM_WT    Fold change   *P*\_value   *q*\_value   Gene_id       Gene       Locus    FPKM_Tpm1.12   FPKM_WT   Fold change   *P*\_value   *q*\_value   Gene_id
  ------------------------------------- ------------------------------------ ------------- ---------- ------------- ------------ ------------ ------------- ---------- -------- -------------- --------- ------------- ------------ ------------ -------------
  Tpm4.2 undiff. top 10 downregulated   Tpm4.2 undiff. Top 10 up‐regulated                                                                                                                                                                       
  Dusp27                                chr13                                4.9844        0.451684   −3.46403      5.00E‐05     0.00040997   XLOC_006430   Foxa2      chr3     0.139538       5.6427    5.33765       0.00205      0.0102548    XLOC_012735
  Nefl                                  chr15                                18.1987       1.67599    −3.44074      5.00E‐05     0.00040997   XLOC_007467   --         chr5     0.0987955      3.14325   4.99167       0.0001       0.00076825   XLOC_016486
  Pcdh20                                chr15:                               1.32061       0.133191   −3.30964      5.00E‐05     0.00040997   XLOC_007835   Pdpn       chr5     0.476489       13.7824   4.85424       5.00E‐05     0.00040997   XLOC_016368
  --                                    chr12:                               4.14833       0.470832   −3.13925      0.00465      0.020115     XLOC_005870   --         chr12    0.178894       4.40403   4.62165       0.0026       0.0124381    XLOC_005595
  --                                    chr19                                3.87688       0.456691   −3.08561      5.00E‐05     0.00040997   XLOC_010104   Qprt       *chr1*   0.281843       6.36273   4.49668       0.00065      0.00391153   XLOC_002237
  Ptpn7                                 chr13                                12.2785       1.481      −3.05149      5.00E‐05     0.00040997   XLOC_006040   Igf2 bp1   chr10    0.194826       3.9438    4.33933       5.00E‐05     0.00040997   XLOC_004304
  --                                    chr5                                 6.19394       0.755452   −3.03545      0.01325      0.0466401    XLOC_016457   Bnc1       chr1     0.454089       6.59516   3.86036       5.00E‐05     0.00040997   XLOC_001936
  Chrna7                                chr1                                 1.76376       0.221772   −2.9915       0.00385      0.0172417    XLOC_001872   --         chrX     0.762958       10.7143   3.81179       5.00E‐05     0.00040997   XLOC_021139
  --                                    chr16                                8.87033       1.13533    −2.96588      0.0001       0.00076825   XLOC_008471   Spon1      chr1     0.289794       3.44618   3.5719        5.00E‐05     0.00040997   XLOC_000788
  --                                    chr7                                 4.60091       0.598227   −2.94315      0.0114       0.0413927    XLOC_018791   Spp1       chr14    0.153611       1.66596   3.439         0.0056       0.0233655    XLOC_006940
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Differentiated Tpm1.12‐, Tpm3.1‐, and Tpm4.2‐overexpressing B35 cells exhibit upregulation of similar genes {#feb412386-sec-0012}
-----------------------------------------------------------------------------------------------------------

*Arhgap25* was among the top upregulated genes in differentiated Tpm1.12‐, Tpm3.1‐, and Tpm4.2‐overexpressing cells, but not in Tpm2.1‐overexpressing cells (Table [2](#feb412386-tbl-0002){ref-type="table-wrap"}). Interestingly, *Arhgap25* encodes negative regulators of Rho‐GTPases, which are involved in actin remodeling, cell polarity, and migration [26](#feb412386-bib-0026){ref-type="ref"}. The upregulation of *Arhgap25*, only in response to cellular differentiation, suggests that in the differentiated Tpm1.12, Tpm3.1, and Tpm4.2 cells, Rho‐GTPases such as Rac or Cdc42 need to be silenced in order to restrict lamellipodia and filopodia formation [27](#feb412386-bib-0027){ref-type="ref"}. By contrast, differentiation of Tpm2.1 cells resulted in increases in genes that encode for proteins, such as *Kcnn4* and *Qprt*, which alter cell membrane polarization (Table [2](#feb412386-tbl-0002){ref-type="table-wrap"}).

###### 

Top 10 up‐ and downregulated genes in differentiated B35 neuroblastoma cells overexpressing tropomyosin isoforms Tpm1.12, Tpm2.1, Tpm3.1, and Tpm4.2

  Gene                                 Locus                               FPKM_Tpm1.12   FPKM_WT     Fold change   *P*\_value   *q*\_value   Gene_id       Gene       Locus   FPKM_Tpm1.12   FPKM_WT   Fold change   *P*\_value   *q*\_value   Gene_id
  ------------------------------------ ----------------------------------- -------------- ----------- ------------- ------------ ------------ ------------- ---------- ------- -------------- --------- ------------- ------------ ------------ -------------
  Tpm1.12 diff. top 10 downregulated   Tpm1.12 diff. top 10 up‐regulated                                                                                                                                                                        
  Il1rl1                               chr9                                1.59718        0.0488129   −5.03212      0.0001       0.0130135    XLOC_021158   Arhgap25   chr4    0.102724       3.17721   4.95092       5.00E‐05     0.00745967   XLOC_015519
  Krt42                                chr10                               9.03038        0.286724    −4.97705      0.00035      0.034033     XLOC_004469   Cyp3a62    chr12   1.88881        37.393    4.30722       5.00E‐05     0.00745967   XLOC_005540
  Myod1                                chr1                                9.5611         0.483197    −4.30649      5.00E‐05     0.00745967   XLOC_000524   --         chr1    0.137797       2.2002    3.99702       5.00E‐05     0.00745967   XLOC_000041
  Tpm1                                 chr8                                1512.31        88.6023     −4.09327      5.00E‐05     0.00745967   XLOC_020658   --         chr20   0.272328       3.87344   3.8302        0.0005       0.0437861    XLOC_012272
  Hmx3                                 chr1                                6.37178        0.391157    −4.02588      5.00E‐05     0.00745967   XLOC_000928   Rab15      chr6    0.182536       2.5494    3.80391       5.00E‐05     0.00745967   XLOC_017959
  Lox                                  chr18                               5.82529        0.36726     −3.98746      5.00E‐05     0.00745967   XLOC_009836   Adh1       chr2    0.344197       3.43627   3.31954       0.0002       0.022638     XLOC_011172
  Wnt7b                                chr7                                6.69696        0.428724    −3.96538      5.00E‐05     0.00745967   XLOC_019352   Kcnn4      chr1    0.478335       3.63281   2.925         5.00E‐05     0.00745967   XLOC_000329
  RGD1563159                           chr18                               2.89636        0.255698    −3.50173      0.0006       0.0495171    XLOC_009800   Car8       chr5    0.839724       6.01935   2.84162       0.0001       0.0130135    XLOC_016561
  --                                   chr4                                58.7075        5.6362      −3.38075      5.00E‐05     0.00745967   XLOC_015812   Col2a1     chr7    2.69563        17.742    2.71847       5.00E‐05     0.00745967   XLOC_019400
  Kit                                  chr14                               1.55982        0.155265    −3.32858      5.00E‐05     0.00745967   XLOC_007261   Mmp2       chr19   18.7413        112.613   2.58709       5.00E‐05     0.00745967   XLOC_010294

  Gene                                Locus                              FPKM_Tpm2.1   FPKM_WT     Fold change   *P*\_value   *q*\_value   Gene_id       Gene      Locus   FPKM_Tpm2.1   FPKM_WT   Fold change   *P*\_value   *q*\_value   Gene_id
  ----------------------------------- ---------------------------------- ------------- ----------- ------------- ------------ ------------ ------------- --------- ------- ------------- --------- ------------- ------------ ------------ -------------
  Tpm2.1 diff. top 10 downregulated   Tpm2.1 diff. top 10 up‐regulated                                                                                                                                                                     
  MGC114427                           chrX                               20.2284       1.27503     −3.98777      5.00E‐05     0.00745967   XLOC_022195   Cyp3a62   chr12   0.798617      37.393    5.54912       5.00E‐05     0.00745967   XLOC_005540
  Hs6st2                              chrX                               1.22422       0.0811244   −3.91558      5.00E‐05     0.00745967   XLOC_022531   --        chr20   0.322848      3.87344   3.58469       0.0005       0.0437861    XLOC_012272
  RGD1563159                          chr18                              2.95816       0.255698    −3.53219      0.00055      0.046874     XLOC_009800   Kcnn4     chr1    0.326822      3.63281   3.47451       5.00E‐05     0.00745967   XLOC_000329
  --                                  chr12                              10.0635       1.02525     −3.29509      0.0003       0.0304187    XLOC_005835   Qprt      chr1    0.599728      6.25604   3.38287       5.00E‐05     0.00745967   XLOC_002288
  Enpp2                               chr7                               1.5044        0.162351    −3.212        0.0006       0.0495171    XLOC_019171   Col2a1    chr7    1.90447       17.742    3.21971       5.00E‐05     0.00745967   XLOC_019400
  --                                  chr14                              4.84023       0.632595    −2.93572      5.00E‐05     0.00745967   XLOC_006938   Slc27a3   chr2    0.209313      1.69112   3.01425       5.00E‐05     0.00745967   XLOC_011597
  RGD1562638                          chr16                              2.90249       0.385049    −2.91418      5.00E‐05     0.00745967   XLOC_008380   Pcsk9     chr5    0.295631      2.07142   2.80875       5.00E‐05     0.00745967   XLOC_016796
  --                                  chr12                              1.6546        0.223779    −2.88634      0.0003       0.0304187    XLOC_005779   Magea11   chrX    2.2022        14.4629   2.71534       5.00E‐05     0.00745967   XLOC_022188
  LOC100302465                        chr1                               20.4765       3.02484     −2.75904      5.00E‐05     0.00745967   XLOC_002336   --        chr5    0.820127      5.38397   2.71475       5.00E‐05     0.00745967   XLOC_016535
  Hmx3                                chr1                               2.58082       0.391157    −2.72201      5.00E‐05     0.00745967   XLOC_000928   Capn6     chrX    0.426284      2.42179   2.50619       0.00025      0.0266766    XLOC_022475

  Gene                                Locus                              FPKM_Tpm3.1   FPKM_WT     Fold change   *P*\_value   *q*\_value   Gene_id       Gene       Locus   FPKM_Tpm3.1   FPKM_WT   Fold change   *P*\_value   *q*\_value   Gene_id
  ----------------------------------- ---------------------------------- ------------- ----------- ------------- ------------ ------------ ------------- ---------- ------- ------------- --------- ------------- ------------ ------------ -------------
  Tpm3.1 diff. top 10 downregulated   Tpm3.1 diff. top 10 up‐regulated                                                                                                                                                                      
  Enpp2                               chr7                               24.6796       0.162351    −7.24806      0.0001       0.0130135    XLOC_019171   Cyp3a62    chr12   1.04867       37.393    5.15614       5.00E‐05     0.00745967   XLOC_005540
  Prrx1                               chr13                              4.94714       0.0731377   −6.07983      0.0002       0.022638     XLOC_006645   Arhgap25   chr4    0.296596      3.17721   3.42119       5.00E‐05     0.00745967   XLOC_015519
  Col3a1                              chr9                               23.4538       0.808091    −4.85916      5.00E‐05     0.00745967   XLOC_021174   Rasal3     chr7    0.92198       7.6725    3.05689       5.00E‐05     0.00745967   XLOC_018972
  --                                  chr16                              14.9788       0.625436    −4.58191      5.00E‐05     0.00745967   XLOC_008386   Slc30a3    chr6    2.96113       16.6391   2.49036       5.00E‐05     0.00745967   XLOC_017347
  Wnt16                               chr4                               3.20669       0.135369    −4.56612      5.00E‐05     0.00745967   XLOC_014664   Nkx2‐8     chr6    3.62869       20.149    2.47319       5.00E‐05     0.00745967   XLOC_017909
  --                                  chr8                               1.72658       0.112733    −3.93694      5.00E‐05     0.00745967   XLOC_020613   Rgs16      chr13   0.719619      3.38166   2.23243       0.00015      0.0182456    XLOC_006309
  Hs6st2                              chrX                               1.16506       0.0811244   −3.84413      5.00E‐05     0.00745967   XLOC_022531   --         chr2    4.50913       20.1249   2.15806       0.00055      0.046874     XLOC_011019
  --                                  chr19                              3.2643        0.247639    −3.72046      5.00E‐05     0.00745967   XLOC_010230   Hsd11b1    chr13   0.880275      3.73038   2.0833        0.0006       0.0495171    XLOC_006786
  Slc14a1                             chr18                              27.2188       2.33361     −3.54397      5.00E‐05     0.00745967   XLOC_009903   Mcoln3     chr2    0.771953      3.15482   2.03097       5.00E‐05     0.00745967   XLOC_011198
  Wnt5a                               chr16                              1.1231        0.0965497   −3.54007      0.00035      0.034033     XLOC_008210   Cryab      chr8    11.7217       46.2096   1.97902       5.00E‐05     0.00745967   XLOC_019966

  Gene                                Locus                              FPKM_Tpm4.2   FPKM_WT    Fold change   *P*\_value   *q*\_value   Gene_id       Gene       Locus   FPKM_Tpm4.2   FPKM_WT   Fold change   *P*\_value   *q*\_value   Gene_id
  ----------------------------------- ---------------------------------- ------------- ---------- ------------- ------------ ------------ ------------- ---------- ------- ------------- --------- ------------- ------------ ------------ -------------
  Tpm4.2 diff. top 10 downregulated   Tpm4.2 diff. top 10 up‐regulated                                                                                                                                                                     
  Myod1                               chr1                               28.5968       0.483197   −5.8871       5.00E‐05     0.00745967   XLOC_000524   Spint2     chr1    0.423831      4.9636    3.54983       0.00035      0.034033     XLOC_001727
  Car3                                chr2                               28.0891       1.45161    −4.27428      5.00E‐05     0.00745967   XLOC_011390   Col2a1     chr7    1.57159       17.742    3.49687       5.00E‐05     0.00745967   XLOC_019400
  Krt15                               chr10                              303.929       17.8834    −4.08704      5.00E‐05     0.00745967   XLOC_004463   Arhgap25   chr4:   0.482218      3.17721   2.72          5.00E‐05     0.00745967   XLOC_015519
  Med12l                              chr2                               3.3854        0.213251   −3.9887       5.00E‐05     0.00745967   XLOC_010857   Kcnn4      chr1    0.678271      3.63281   2.42115       5.00E‐05     0.00745967   XLOC_000329
  Atp1a3                              chr1                               4.88898       0.450264   −3.44069      5.00E‐05     0.00745967   XLOC_001683   Calcb      chr1    3.10533       16.2157   2.38457       5.00E‐05     0.00745967   XLOC_000822
  Efna5                               chr9                               1.64816       0.152239   −3.43644      0.00035      0.034033     XLOC_021706   --         chrX    1.53544       7.26066   2.24145       5.00E‐05     0.00745967   XLOC_022048
  --                                  chr2                               15.2347       1.40862    −3.435        0.0001       0.0130135    XLOC_011936   --         chrX    1.46876       6.94188   2.24073       5.00E‐05     0.00745967   XLOC_022391
  Chrna1                              chr3                               183.471       18.6364    −3.29935      5.00E‐05     0.00745967   XLOC_013760   --         chrX    0.596817      2.79741   2.22873       0.00045      0.0405794    XLOC_022361
  Ass1                                chr3                               1.98046       0.211055   −3.23015      0.0001       0.0130135    XLOC_013634   Pcdh7      chr14   0.778927      3.15898   2.0199        0.0001       0.0130135    XLOC_007301
  Trim55                              chr2                               3.14264       0.345104   −3.18687      0.00035      0.034033     XLOC_010770   Shtn1      chr1    0.693723      2.43258   1.81005       0.0004       0.0375237    XLOC_002745
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DEGs arising from the overexpression of tropomyosin isoforms cluster into various pathways {#feb412386-sec-0013}
------------------------------------------------------------------------------------------

In undifferentiated cells, cluster analysis of DEGs from the overexpression of the four tropomyosin isoforms, used in this study, results in the emergence of multiple pathways. In differentiated cells, Tpm3.1 is the only isoform where DEGs cluster into pathways.

### Tpm1.12 {#feb412386-sec-0014}

The DEGs arising from Tpm1.12 overexpression in undifferentiated cells cluster into 15 GO terms (Fig. [2](#feb412386-fig-0002){ref-type="fig"}A). Of these GO terms, ribosomal, RNA, and ubiquitin related are among the pathways holding the highest statistical significance. Ribosomal proteins are most commonly known to be involved in protein synthesis but have also been shown to exert extraribosomal functions including immune signaling and development of various cell types [28](#feb412386-bib-0028){ref-type="ref"} as well as being implicated in various cancers including glioblastoma, gastrointestinal, prostate, and lung [29](#feb412386-bib-0029){ref-type="ref"}, [30](#feb412386-bib-0030){ref-type="ref"}, [31](#feb412386-bib-0031){ref-type="ref"}, [32](#feb412386-bib-0032){ref-type="ref"}. In this study, expression levels of many genes, encoding ribosomal proteins (Rp), were found to be differentially regulated in both Tpm1.12‐ and Tpm2.1‐overexpressing cells including *Rpl9, Rpl13, Rpl19,* and *Rpl22*.

![Pathway analysis of DEGs from undifferentiated and differentiated B35 cells overexpressing Tpm isoforms. (A--D) Overexpression of Tpm1.12, Tpm2.1, Tpm3.1, and Tpm4.2 in undifferentiated B35 cells generates DEGs that cluster into various GO terms. (E) GO terms generated from the clustering of DEGs from Tpm3.1 overexpression in differentiated B35 cells.](FEB4-8-570-g002){#feb412386-fig-0002}

In the GTPase binding GO term, the *Pfn1* (profilin 1) is found to be upregulated. Pfn1 is involved in actin nucleation, mediating the exchange of ADP to ATP on monomeric actin. This process primes the actin monomer to be incorporated into the growing 'barbed end' of actin filaments, resulting in actin filament polymerization [33](#feb412386-bib-0033){ref-type="ref"}. Overexpression of Tpm1.12 has previously been shown to promote neurite branching and filopodia formation [13](#feb412386-bib-0013){ref-type="ref"}, two processes that rely on polymerization of actin filaments. The upregulation of *Pfn1* is a potential mechanism by which Tpm1.12 is able to enhance neurite branching and filopodia formation in the cell.

### Tpm2.1 {#feb412386-sec-0015}

Differentially expressed genes from undifferentiated cells overexpressing Tpm2.1 cluster into 7 GO terms (Fig. [2](#feb412386-fig-0002){ref-type="fig"}B), rRNA binding, structural constituent of ribosome, threonine‐type endopeptidase activity, threonine‐type peptidase activity, large ribosomal subunit rRNA binding, protein C‐terminal binding, and growth factor binding. Within the protein C‐terminal‐binding protein pathway are genes, associated with apoptosis. Tpm2.1 is known to have tumor‐suppressing properties in breast and urinary bladder cancers [10](#feb412386-bib-0010){ref-type="ref"}, [34](#feb412386-bib-0034){ref-type="ref"}, [35](#feb412386-bib-0035){ref-type="ref"} and has recently been shown to increase cell sensitivity to apoptosis by detachment from the extracellular matrix, referred to as anoikis, and through the modulation of various apoptosis‐inducing proteins [17](#feb412386-bib-0017){ref-type="ref"}.

In this study, the overexpression of Tpm2.1 shows upregulation of *Dapk3* (death‐associated protein kinase 3) and downregulation of *Cdc37* (cell division cycle 37) gene expression levels. These two genes are involved in apoptosis and clustered into the protein C‐terminal GO term (Fig. [2](#feb412386-fig-0002){ref-type="fig"}B). The Dapk family are actin cytoskeleton‐associated Ca2 + /calmodulin (CaM)‐regulated serine/threonine kinases reported to regulate cell death via various mechanisms including interferon‐γ, c‐Myc, and anoikis [36](#feb412386-bib-0036){ref-type="ref"}, [37](#feb412386-bib-0037){ref-type="ref"}, [38](#feb412386-bib-0038){ref-type="ref"}, [39](#feb412386-bib-0039){ref-type="ref"}. Dapk3 has been shown to exert apoptotic function through mitochondrial pathways [40](#feb412386-bib-0040){ref-type="ref"} and to have tumor‐suppressing qualities [38](#feb412386-bib-0038){ref-type="ref"}, [41](#feb412386-bib-0041){ref-type="ref"}, [42](#feb412386-bib-0042){ref-type="ref"}.

Cdc37 is a cochaperone protein to heat‐shock protein 90 (HSP90). Cdc37 facilitates the interaction of protein kinases with HSP90 by arresting the ATPase cycle of HSP90 and inducing an open conformational state that promotes client protein interaction [43](#feb412386-bib-0043){ref-type="ref"}. HSP90 in collaboration with Cdc37 has been suggested to promote the proliferation and survival of cancer cells through dysregulation of oncogenes [44](#feb412386-bib-0044){ref-type="ref"}, and silencing Cdc37 has been shown to enhance cell cycle arrest and apoptosis [45](#feb412386-bib-0045){ref-type="ref"}, [46](#feb412386-bib-0046){ref-type="ref"}, [47](#feb412386-bib-0047){ref-type="ref"}.

In our study, Tpm2.1 overexpression results in the upregulation of *Dapk3* and the downregulation of *Cdc37* genes. The ability of Tpm2.1 to modulate the expression of these genes may help to shed light onto the tumor‐suppressing and proapoptotic characteristics of Tpm2.1.

### Tpm4.2 {#feb412386-sec-0016}

Differentially expressed genes that were observed in response to the overexpression of Tpm4.2 cluster into six GO terms, protein C‐terminal binding, growth factor binding, actin binding, extracellular matrix binding, glycosaminoglycan binding, and integrin binding (Fig. [2](#feb412386-fig-0002){ref-type="fig"}C).

The integrin‐binding pathway includes genes for integrin subunits. Integrins function in cell surface adhesion and signaling, acting as a mediator between the intracellular actin cytoskeleton and the extracellular matrix [48](#feb412386-bib-0048){ref-type="ref"}. Gene expression of *Itga7* (Integrin subunit α7) is found to be upregulated in response to Tpm4.2 overexpression in undifferentiated B35 cells. Itga7 and β‐subunits form heterodimeric integrin receptors that bind laminin and regulate cell adhesion [49](#feb412386-bib-0049){ref-type="ref"}. Interestingly, Itga7 has been found to play a role in lamellipodia formation [50](#feb412386-bib-0050){ref-type="ref"}, neuritogenesis of cortical neurons [51](#feb412386-bib-0051){ref-type="ref"}, and the regeneration of subpopulations of injured sensory neurons [52](#feb412386-bib-0052){ref-type="ref"}. In a previous study by Curthoys *et al*. [13](#feb412386-bib-0013){ref-type="ref"}, overexpression of Tpm4.2 in undifferentiated B35 neuroblastoma cells led to an increase in neurite branching, filopodia formation, and growth cone size. It is plausible that this observed phenotype may be promoted by the ability of Tpm4.2 to modulate genetic expression of genes such as Itga7. Furthermore, overexpression of Tpm4.2 increases protein levels of fascin [13](#feb412386-bib-0013){ref-type="ref"}, an actin‐binding protein recruited to actin bundles during filopodia and lamellipodia formation [53](#feb412386-bib-0053){ref-type="ref"}.

### Tpm3.1 {#feb412386-sec-0017}

Gene ontology terms arising from overexpression of Tpm3.1 in undifferentiated cells include growth factor‐binding, protein C‐terminal‐binding, fibronectin‐binding, and actin‐binding pathways among others (Fig. [2](#feb412386-fig-0002){ref-type="fig"}D).

The protein C‐terminal‐binding and fibronectin‐binding pathways comprise genes involved in cell adhesion, migration, and motility including *Fbln5* (fibulin‐5) and *Itga4* (integrin subunit gene α4).

Fbln5 is an extracellular matrix protein involved cell adhesion. In endothelial cells, Fbln5 has been shown to operate via integrin binding [54](#feb412386-bib-0054){ref-type="ref"} enhancing cell attachment and adhesion as well as decreasing proliferation [55](#feb412386-bib-0055){ref-type="ref"}. Interestingly, Fbln5 is reported to have context‐dependent oncogenic and tumor‐suppressing roles [56](#feb412386-bib-0056){ref-type="ref"}. Increased levels of Fbln5 reduce cell migration and invasion in ovarian and breast cancer [57](#feb412386-bib-0057){ref-type="ref"}, [58](#feb412386-bib-0058){ref-type="ref"}.

Itga4 and β1‐subunits form integrin heterodimers that bind fibronectin, increasing focal adhesion and cell motility [59](#feb412386-bib-0059){ref-type="ref"}. Furthermore, the cytoplasmic tail of α4 integrins binds actin filament‐bound nonmuscle myosin IIa to regulate cell migration [60](#feb412386-bib-0060){ref-type="ref"}.

In the current study, overexpression of Tpm3.1 upregulates the expression levels of both *Fbnl5* and *Itga4*. Previously, Tpm3.1 has been shown to recruit myosin IIa into stress fibers, stabilize actin filaments, and slow cell migration [9](#feb412386-bib-0009){ref-type="ref"}, [14](#feb412386-bib-0014){ref-type="ref"}, [19](#feb412386-bib-0019){ref-type="ref"}. It is plausible then that Tpm3.1 works in conjunction with Fbln5, Itga4, and myosin IIa to enhance cell stability and adhesion.

### Tpm3.1 overexpression in differentiated B35 cells {#feb412386-sec-0018}

Interestingly, in differentiated cells, Tpm3.1 was the only isoform that generated GO terms from cluster analysis of DEGs (Fig. [2](#feb412386-fig-0002){ref-type="fig"}E). The GO terms observed include growth factor‐binding, glycosaminoglycan‐binding, water transmembrane transporter activity, RNA polymerase II transcription coactivator activity GO terms (Fig. [2](#feb412386-fig-0002){ref-type="fig"}E). The greatest difference was observed in the GO terms growth factor binding and glycosaminoglycan binding. Differentiated Tpm3.1 cells have increased levels of fibroblast growth factor receptors 1 and 2 (*Fgfr1* and *Fgfr2*, respectively). Increased expression of Fgfr1 is associated with parathyroid carcinoma [61](#feb412386-bib-0061){ref-type="ref"}. Tpm3.1 is the predominant Tpm isoform in numerous cancers [7](#feb412386-bib-0007){ref-type="ref"}. Taken together, Fgfr1 and Tpm3.1 could be working synergistically during cancer development. Furthermore, Fgfr2 expression is upregulated in differentiating mouse podocytes *in vitro*, due to the reorganization of the actin cytoskeleton and extension of their cellular processes [62](#feb412386-bib-0062){ref-type="ref"}. Therefore, as B35 cells overexpressing Tpm3.1 undergo differentiation, they may require increased levels of Fgfr1 and Fgfr2 to accommodate the reorganization of the actin cytoskeleton.

Actin‐binding pathway {#feb412386-sec-0019}
---------------------

Undifferentiated B35 cells overexpressing either Tpm3.1 or Tpm4.2 are found to differentially regulate genes that cluster into the actin‐binding GO term (Table [3](#feb412386-tbl-0003){ref-type="table-wrap"}). Both Tpm3.1‐ and Tpm4.2‐overexpressing B35 cells show altered genetic read levels of members of the Coronin family. In particular, *Coro1a* is upregulated in both Tpm3.1‐ and Tpm4.2‐overexpressing cells. The role of the Coronin family has been well described in immune cells, with recent evidence also suggesting a role in neuronal cells [63](#feb412386-bib-0063){ref-type="ref"}. Interestingly, CORO1A is associated with polarized cells, suggesting that it is required for active actin cytoskeleton rearrangement and protein synthesis [63](#feb412386-bib-0063){ref-type="ref"}. Furthermore, members of the type 1 Coronin family typically localize to protrusions of cell membranes, where they modulate actin dynamics [64](#feb412386-bib-0064){ref-type="ref"}. Therefore, the increased neurite outgrowth and axonal extension known to be associated with increased Tpm3.1 expression [65](#feb412386-bib-0065){ref-type="ref"}, [66](#feb412386-bib-0066){ref-type="ref"}, [67](#feb412386-bib-0067){ref-type="ref"} may be assisted by increased *Coro1a* levels. Further investigations are needed to elucidate the interaction between Coro1a and Tpm3.1/Tpm4.2.

###### 

Overexpression of tropomyosin isoforms Tpm1.12, Tpm3.1, and Tpm4.2 differentially regulates the expression of genes involved in actin binding

  Gene                                           Locus   FPKM_Tpm3.1   FPKM_WT   Fold change   *P*\_value   *q*\_value    Gene_id
  ---------------------------------------------- ------- ------------- --------- ------------- ------------ ------------- -------------
  Tpm3.1 undiff. DEGs in actin‐binding pathway                                                                            
  Coro1a                                         chr1    33.3272       19.2652   −0.790702     5.00E‐05     0.000409973   XLOC_002225
  Fmnl1                                          chr10   1.16689       2.0026    0.779204      0.00185      0.00941884    XLOC_003627
  Myh10                                          chr10   6.3366        10.0299   0.66253       5.00E‐05     0.000409973   XLOC_003283
  Myo7a                                          chr1    17.4539       9.04809   −0.94786      5.00E‐05     0.000409973   XLOC_001985
  Limch1                                         chr14   12.9913       20.9554   0.689775      5.00E‐05     0.000409973   XLOC_007048
  Twf2                                           chr8    14.5084       21.8628   0.591586      0.0001       0.000768253   XLOC_019311

  Gene                                           Locus   FPKM_Tpm4.2   FPKM_WT    Fold change   *P*\_value   *q*\_value    Gene_id
  ---------------------------------------------- ------- ------------- ---------- ------------- ------------ ------------- -------------
  Tpm4.2 undiff. DEGs in actin‐binding pathway                                                                             
  Marcksl1                                       chr1    20.8434       28.8606    0.469513      0.00785      0.0307347     XLOC_001671
  Coro1a                                         chr1    31.1256       19.2652    −0.692101     5.00E‐05     0.000409973   XLOC_002225
  Myh10                                          chr10   3.76493       10.0299    1.41362       5.00E‐05     0.000409973   XLOC_003283
  Myh1                                           chr10   58.7752       32.3774    −0.860222     5.00E‐05     0.000409973   XLOC_003272
  Slc6a4                                         chr10   2.18532       6.9866     1.67674       5.00E‐05     0.000409973   XLOC_004178
  Tmod2                                          chr8    2.31106       0.981818   −1.23503      0.00015      0.00110539    XLOC_019804

  Gene                                            Locus   FPKM_Tpm1.12   FPKM_WT   Fold change   *P*\_value   *q*\_value    Gene_id
  ----------------------------------------------- ------- -------------- --------- ------------- ------------ ------------- -------------
  Tpm1.12 undiff. DEGs in actin‐binding pathway                                                                             
  Marcksl1                                        chr1    0.456449       1.35277   1.56739       5.00E‐05     0.000409973   XLOC_001670
  Coro1a                                          chr1    30.2034        19.2652   −0.648712     5.00E‐05     0.000409973   XLOC_002225
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Despite their commonalities, Tpm3.1 overexpression and Tpm4.2 overexpression also result in differential changes in genes from the GO terms actin‐binding pathway. Whereas the overexpression of Tpm4.2 results in a decrease in *Marcksl1*, this is not observed for Tpm3.1. Marcksl1 is an actin cross‐linking protein, which undergoes phosphorylation to bundle and stabilize F‐actin [68](#feb412386-bib-0068){ref-type="ref"}. The inhibition of Marcksl1 phosphorylation causes an increase in actin mobility, compromised filopodia formation, enhanced lamellipodium formation, and cell migration [68](#feb412386-bib-0068){ref-type="ref"}. Therefore, the increase in filopodia number previously observed in Tpm4.2‐overexpressing cells [13](#feb412386-bib-0013){ref-type="ref"} may be partly attributed to a concomitant decrease in *Marcksl1*.

Although the overexpression of Tpm1.12 did not lead to DEGs clustering to form an actin‐binding pathway, both *Coro1a* and *Marcksl1* genes are found to be differentially expressed. As observed in Tpm4.2 overexpression, Tpm1.12 overexpression upregulates *Coro1a* and downregulates *Marcksl1* (Table [3](#feb412386-tbl-0003){ref-type="table-wrap"}). The similar changes, induced by Tpm4.2 and Tpm1.12, are consistent with the study by Curthoys *et al*. [13](#feb412386-bib-0013){ref-type="ref"}, where overexpression of Tpm1.12 was found to have similar effects on cell morphology as Tpm4.2, with an increase in filopodia and neurite branching.

Potential mechanisms for transcriptional changes caused by Tpm expression {#feb412386-sec-0020}
-------------------------------------------------------------------------

Our data demonstrate that Tpm expression leads to isoform‐dependent transcriptional changes in eukaryotic cells. The mechanisms by which Tpms lead to these transcriptional changes are still unknown. A role for actin in transcriptional regulation has been well established and reviewed previously [69](#feb412386-bib-0069){ref-type="ref"}, [70](#feb412386-bib-0070){ref-type="ref"}. A potential mechanism of transcriptional regulation by Tpms may be via Tpm isoform‐dependent regulation of actin turnover which is important for the localization of transcriptional regulators. Maintaining the balance between the globular (G) and the filamentous (F) pool of cytoplasmic actin has been implicated in the translocation several transcriptional regulators, including the homeobox transcription factor PREP2 [71](#feb412386-bib-0071){ref-type="ref"}, the transcriptional repressor YY1 [72](#feb412386-bib-0072){ref-type="ref"}, and the transcriptional coactivator MAL [73](#feb412386-bib-0073){ref-type="ref"}. Regulation of the cytoplasmic pool of G‐ and F‐actin by the expression levels of different Tpms could therefore impact the transcriptome as a consequence of altered translocation of these transcriptional regulators. Tpms have also been found in the nucleus [74](#feb412386-bib-0074){ref-type="ref"}, [75](#feb412386-bib-0075){ref-type="ref"}, where they may directly regulate transcription of the genes that group in various pathways identified in our study.

Conclusion {#feb412386-sec-0021}
==========

In conclusion, overexpression of Tpm isoforms in undifferentiated B35 neuroblastoma cells leads to the differential expression of a plethora of genes. However, once differentiated, Tpm isoforms have a weaker influence on gene expression. In undifferentiated cells, DEGs cluster into various pathways that show some similarity between isoforms. In differentiated cells, the overexpression of Tpm3.1 was the only isoform to generate GO terms. Many of the observed DEGs are involved in cellular activities that relate to Tpm functions, suggesting that Tpms can modulate cell dynamics and properties by regulating specific genes. Overall, this study highlights the ability of Tpm isoforms to regulate patterns of gene expression in an isoform‐specific manner and aligns with their capacity to similarly control actin filament function.
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